Pennsylvania lawmakers must pass bills to protect families from the crushing financial burden that follows tragedy, writes a ...

Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 3.2% in the afternoon session after TD Cowen ...

Roche expects filing for up to three new molecular entities in 2026, and accelerating its pipeline through partnerships and ...

After a busy first day featuring headlines from a who's who of leading biopharma companies, the J.P. | The J.P. Morgan ...

Detailed price information for Adc Therapeutics Sa (ADCT-N) from The Globe and Mail including charting and trades.

Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

According to Van de Winkel, Genmab is set to enter 2026 with an improved balanced across its earnings, mixing royalties and ...

The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...

Preliminary unaudited fourth quarter and full year 2025 net product revenue of approximately $22M and $73M respectively; cash ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a ...